Legal information
These documents are drafts and are not in force. They describe what COHESORA actually does today so that a qualified lawyer can review them. They are not legal advice and are not yet an agreement between INVICTT AI and any customer.
- Version: Draft 0.1
- Effective date: Not in force — no effective date has been set
- Review: Awaiting review by a qualified lawyer (UK data-protection and commercial law)
- Entity: INVICTT AI. The legal entity name, registration number and registered address are not yet published and must be added before these documents can take effect.
- Terms of ServiceThe agreement between an accounting firm and INVICTT AI for using COHESORA.
- Privacy NoticeHow COHESORA handles personal data. For the INVICTT website's own notice see invictt.com/privacy.
- Data Processing AgreementTerms under which INVICTT AI processes personal data on behalf of an accounting firm (UK GDPR Article 28 outline).
- Subprocessors and service providersThe third parties that handle data to deliver COHESORA, as actually configured today.
- Acceptable Use PolicyWhat may not be done with COHESORA.
- Data retention and deletionHow long data is kept and how it is deleted, as implemented.
- Trial termsHow the 14-day trial works.
- Information security policySecurity measures that exist today and what is not claimed.
- Cookie policyThe cookies and browser storage COHESORA uses — all strictly necessary; no analytics or advertising.
- International data transfersWhere data goes outside the UK and the mechanisms that would cover it — to be confirmed by counsel.
- Service levelsWhat availability and support can honestly be expected today. There is no service-level agreement.
- Client portal termsFor clients of an accounting firm who use the COHESORA client portal.
- Data breach and incident response procedureHow a security incident would be handled, written from the current operational reality.
Questions or concerns: Support. The INVICTT website has its own notice at invictt.com/privacy; it does not cover COHESORA.